Identifying the Common Cell-Free DNA Biomarkers across Seven Major Cancer Types
Blood-based detection of circulating cell-free DNA (cfDNA) is a non-invasive and easily accessible method for early cancer detection. Despite the extensive utility of cfDNA, there are still many challenges to developing clinical biomarkers. For example, cfDNA with genetic alterations often composes...
Main Authors: | Mingyu Luo, Yining Liu, Min Zhao |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-06-01
|
Series: | Biology |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-7737/12/7/934 |
Similar Items
-
Genome-wide discovery of circulating cell-free DNA methylation biomarkers for colorectal cancer detection
by: Qingxiao Fang, et al.
Published: (2023-07-01) -
Integrative analysis identifies potential DNA methylation biomarkers for pan-cancer diagnosis and prognosis
by: Wubin Ding, et al.
Published: (2019-01-01) -
Circulating cell-free DNA-based methylation pattern in plasma for early diagnosis of esophagus cancer
by: Rui Wang, et al.
Published: (2024-01-01) -
New approaches for detecting cancer with circulating cell-free DNA
by: Clare Fiala, et al.
Published: (2019-08-01) -
Circulating Cell-Free DNA in Liquid Biopsies as Potential Biomarker for Bladder Cancer: A Systematic Review
by: Raquel Herranz, et al.
Published: (2021-03-01)